RMC No. 103-2021: Publishes the full text of the letters from the Food and Drug Administration and the Department of Health containing updates to the List of VAT-Exempt Products under Republic Act (RA) Nos. 10963, 11467 and 11534

Summary

RMC No. 103-2021 publishes the full text of letters from the FDA and the Department of Health with updates to the List of VAT-Exempt Products under RA Nos. 10963, 11467 and 11534.

Key points

1. FDA letter. A letter dated August 31, 2021 from Dr. Rolando Enrique D. Domingo, Director General of the FDA, comes with the Corrigendum to the List of Medicines for Hypertension, Cancer and Kidney Diseases.
2. DOH letter. A letter dated August 12, 2021 from Dr. Gerardo V. Bayugo, Undersecretary of Health, comes with the List of VAT-Exempt Drugs and Vaccines Prescribed and Directly Used for COVID-19 Treatment.
3. Relation to RMC No. 81-2021. This circular updates and supplements RMC No. 81-2021, which published the consolidated list that controls the VAT exemption under Sections 109(1)(AA) and 109(1)(BB)(ii) of the Tax Code. The full list is at https://verification.fda.gov.ph/Home.php.

Deadlines and effectivity

• Letters dated August 31, 2021 and August 12, 2021

Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.